APO RESEARCH · REPORT
Clinical Trial Supplies
A safe clinical trial presupposes a robust supply chain management of the study drugs, consistent with various regional and global regulations and available infrastructures.
Product & engineering
Understand the product.
A safe clinical trial presupposes a robust supply chain management of the study drugs, consistent with various regional and global regulations and available infrastructures.
Selected research
Industry Research
Clinical Trial Supplies Industry Research Report 2026
Market perspective
A safe clinical trial presupposes a robust supply chain management of the study drugs, consistent with various regional and global regulations and available infrastructures.
Safe clinical trials are premised on strong supply chain management of the investigational drug, in accordance with regional and global regulations, and in line with local production and development realities. Clinical trial consumable management is critical to avoid overproduction, inventory expiration, and oversupply.As the cost of drug development continues to rise, the supply of clinical trials is becoming ever more important.In addition, strict operational requirements for the implementation of a variety of biopharmaceutical products into clinical trials require constant reform of clinical trial supply strategies.This also requires the integration of multiple third party vendors at all stages of clinical development. Global Clinical Trial Supplies key players include Thermo Fisher Scientific, Catalent Pharma Solutions, Almac Group, Parexel International, UDG Healthcare etc. China top five manufacturers hold a Production Share over 70%. North America accounts for the most Sales Market Share, which have a share over 50%, followed by Europe. In terms of product, Supply Chain Management is the largest segment, with a Market Share over 35%. And in terms of application, the largest Application is Clinical Phase iii.
Report Scope
Read the full market overview
This report quantifies the global Clinical Trial Supplies market in terms of revenue (US$ million) and, where applicable, service volume (Kiloton), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Kiloton) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Clinical Trial Supplies.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Clinical Trial Supplies Market by Company
Thermo Fisher Scientific
Catalent Pharma Solutions
Almac Group
Parexel International
UDG Healthcare
PCI Services
Marken
Clinical Trial Supplies Segment by Type
Logistics & Distribution
Manufacturing and Packaging
Supply Chain Management
Other
Clinical Trial Supplies Segment by Application
Phase I
Phase II
Phase III
Other
Clinical Trial Supplies Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trial Supplies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Trial Supplies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trial Supplies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Clinical Trial Supplies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Logistics & Distribution
- Manufacturing and Packaging
- Supply Chain Management
- Other
Applications
- Phase I
- Phase II
- Phase III
- Other
Companies covered
- Thermo Fisher Scientific
- Catalent Pharma Solutions
- Almac Group
- Parexel International
- UDG Healthcare
- PCI Services
- Marken
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Clinical Trial Supplies by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Logistics & Distribution
- 2.2.3 Manufacturing and Packaging
- 2.2.4 Supply Chain Management
- 2.2.5 Other
- 2.3 Clinical Trial Supplies by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Phase I
- 2.3.3 Phase II
- 2.3.4 Phase III
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Clinical Trial Supplies Breakdown Data by Type
- 3.1 Global Clinical Trial Supplies Historic Market Size by Type (2021-2026)
- 3.2 Global Clinical Trial Supplies Forecasted Market Size by Type (2027-2032)
4 Clinical Trial Supplies Breakdown Data by Application
- 4.1 Global Clinical Trial Supplies Historic Market Size by Application (2021-2026)
- 4.2 Global Clinical Trial Supplies Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Clinical Trial Supplies Market Perspective (2021-2032)
- 5.2 Global Clinical Trial Supplies Growth Trends by Region
- 5.2.1 Global Clinical Trial Supplies Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Clinical Trial Supplies Historic Market Size by Region (2021-2026)
- 5.2.3 Clinical Trial Supplies Forecasted Market Size by Region (2027-2032)
- 5.3 Clinical Trial Supplies Market Dynamics
- 5.3.1 Clinical Trial Supplies Industry Trends
- 5.3.2 Clinical Trial Supplies Market Drivers
- 5.3.3 Clinical Trial Supplies Market Challenges
- 5.3.4 Clinical Trial Supplies Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Clinical Trial Supplies Players by Revenue
- 6.1.1 Global Top Clinical Trial Supplies Players by Revenue (2021-2026)
- 6.1.2 Global Clinical Trial Supplies Revenue Market Share by Players (2021-2026)
- 6.2 Global Clinical Trial Supplies Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Clinical Trial Supplies Head Office and Area Served
- 6.4 Global Clinical Trial Supplies Players, Product Type & Application
- 6.5 Global Clinical Trial Supplies Manufacturers Established Date
- 6.6 Global Clinical Trial Supplies Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Clinical Trial Supplies Market Size (2021-2032)
- 7.2 North America Clinical Trial Supplies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Clinical Trial Supplies Market Size by Country (2021-2026)
- 7.4 North America Clinical Trial Supplies Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Clinical Trial Supplies Market Size (2021-2032)
- 8.2 Europe Clinical Trial Supplies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Clinical Trial Supplies Market Size by Country (2021-2026)
- 8.4 Europe Clinical Trial Supplies Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Clinical Trial Supplies Market Size (2021-2032)
- 9.2 Asia-Pacific Clinical Trial Supplies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Clinical Trial Supplies Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Clinical Trial Supplies Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Clinical Trial Supplies Market Size (2021-2032)
- 10.2 South America Clinical Trial Supplies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Clinical Trial Supplies Market Size by Country (2021-2026)
- 10.4 South America Clinical Trial Supplies Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Clinical Trial Supplies Market Size (2021-2032)
- 11.2 Middle East & Africa Clinical Trial Supplies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Clinical Trial Supplies Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Clinical Trial Supplies Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Clinical Trial Supplies Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Clinical Trial Supplies Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 Catalent Pharma Solutions
- 12.2.1 Catalent Pharma Solutions Company Information
- 12.2.2 Catalent Pharma Solutions Business Overview
- 12.2.3 Catalent Pharma Solutions Revenue in Clinical Trial Supplies Business (2021-2026)
- 12.2.4 Catalent Pharma Solutions Clinical Trial Supplies Product Portfolio
- 12.2.5 Catalent Pharma Solutions Recent Developments
- 12.3 Almac Group
- 12.3.1 Almac Group Company Information
- 12.3.2 Almac Group Business Overview
- 12.3.3 Almac Group Revenue in Clinical Trial Supplies Business (2021-2026)
- 12.3.4 Almac Group Clinical Trial Supplies Product Portfolio
- 12.3.5 Almac Group Recent Developments
- 12.4 Parexel International
- 12.4.1 Parexel International Company Information
- 12.4.2 Parexel International Business Overview
- 12.4.3 Parexel International Revenue in Clinical Trial Supplies Business (2021-2026)
- 12.4.4 Parexel International Clinical Trial Supplies Product Portfolio
- 12.4.5 Parexel International Recent Developments
- 12.5 UDG Healthcare
- 12.5.1 UDG Healthcare Company Information
- 12.5.2 UDG Healthcare Business Overview
- 12.5.3 UDG Healthcare Revenue in Clinical Trial Supplies Business (2021-2026)
- 12.5.4 UDG Healthcare Clinical Trial Supplies Product Portfolio
- 12.5.5 UDG Healthcare Recent Developments
- 12.6 PCI Services
- 12.6.1 PCI Services Company Information
- 12.6.2 PCI Services Business Overview
- 12.6.3 PCI Services Revenue in Clinical Trial Supplies Business (2021-2026)
- 12.6.4 PCI Services Clinical Trial Supplies Product Portfolio
- 12.6.5 PCI Services Recent Developments
- 12.7 Marken
- 12.7.1 Marken Company Information
- 12.7.2 Marken Business Overview
- 12.7.3 Marken Revenue in Clinical Trial Supplies Business (2021-2026)
- 12.7.4 Marken Clinical Trial Supplies Product Portfolio
- 12.7.5 Marken Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst